Mind the (Cell Therapy) Gap - Transforming Patient Care With ATMPs

Patients with long-lasting responses to cell and gene therapies inspire hope for those seeking treatment alternatives. However, the journey of making these Advanced Therapy Medicinal Products (ATMPs) accessible involves navigating a complex landscape, including trial design, the evolving treatment environment, regulatory challenges, scalable manufacturing processes, and a supportive patient community prepared to address the unique challenges of innovative treatment options.

The Flemingsberg Science Foundation in collaboration with Miltenyi Biotec Nordics is organizing an educational seminar to discuss the obstacles and opportunities in fulfilling patient requirements from pre-GMP development to clinical trials. Participants can expect to engage with a community of experts and enthusiasts dedicated to finding efficient ways to provide more ATMP options to a greater number of patients.

This educational initiative highlights the ATMP Flemingsberg brand, which aims to showcase local development in this field. The seminar is free and welcomes practicing scientists and healthcare professionals from both Academia and Industry. Refreshments will be provided.

Attendees should note that they may appear in background video, photo, or audio recordings that could be used for marketing and public relations purposes. If someone is prominently featured, their explicit consent will be sought separately. Please review Miltenyi's Privacy Statement for further information on personal information usage.